{"disease":{"id":"polyneuropathy-inflammatory-demyelinating-chronic","name":"polyneuropathy inflammatory demyelinating chronic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06859099","title":"Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":300,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT06968975","title":"Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT06290128","title":"A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Sanofi","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}